Diabetes & Endocrinology – Page 14

New Diabetes Guidelines Spotlight Preconception Care for Women

By MedXY 07/29/2025

Comprehensive guidelines emphasize preconception care for women with diabetes to reduce pregnancy risks and improve maternal and infant health.

Diabetes & Endocrinology news OB/GYN & Women's Health Specialties

Enhanced Weight Loss for Menopausal Women: The Role of Tirzepatide and Hormone Therapy

By MedXY 07/29/2025

A new study reveals combining tirzepatide and hormone therapy significantly boosts weight loss in postmenopausal women, offering a promising approach to managing obesity-related health risks.

Diabetes & Endocrinology news Specialties

The Rise of Ozempic and Wegovy: Revolutionizing Weight Loss, But At What Cost?

By MedXY 07/28/2025

Semaglutide drugs like Ozempic and Wegovy are transforming obesity treatment, but questions remain about long-term safety, access, and societal impact.

Cardiology Diabetes & Endocrinology news Specialties

Eating Eggs Weekly May Lower Risks of Diabetes and Hypertension

By MedXY 07/27/2025

Recent research suggests that consuming five or more eggs weekly may reduce the risks of diabetes and hypertension, offering a healthier outlook for balanced diets.

Diabetes & Endocrinology news OB/GYN & Women's Health Specialties

Gestational Diabetes: Essential Strategies for a Healthy Pregnancy and Baby

By MedXY 07/27/2025

Discover the crucial details gestational diabetes patients must manage to protect fetal health, informed by science and expert recommendations.

Diabetes & Endocrinology news OB/GYN & Women's Health Specialties

Pregnancy and Diabetes: What Every Patient Needs to Know for a Healthy Journey

By MedXY 07/27/2025

Discover the key precautions and expert advice for women with diabetes considering pregnancy, blending the latest science with real-life advice.

Diabetes & Endocrinology news Specialties

Staying Active with Diabetes: What You Need to Know Before You Exercise

By MedXY 07/27/2025

Discover how people with diabetes can exercise safely and effectively by understanding key considerations, evidence-based practices, and expert advice.

Diabetes & Endocrinology Family Medicine & Nutrition news Specialties

Zero-Sugar, Zero-Calorie Drinks: Can You Really Drink Them Freely While Dieting?

By MedXY 07/26/2025

Are zero-sugar, zero-calorie drinks a dieter's dream or a hidden trap? We unpack the science, misconceptions, and practical advice for healthy weight management.

Diabetes & Endocrinology news Specialties

Choosing the Right Oats for Weight Loss: A Guide to Different Types of Oats

By MedXY 07/26/2025

Explore the benefits of oats for weight loss and learn how to choose the right type for your needs.

Diabetes & Endocrinology news

The End of the Diet? Inside the Game-Changing Anti-Obesity Drug Revolution

By MedXY 07/25/2025

New anti-obesity medications are transforming weight management, challenging old paradigms, and raising new questions about the future of dieting and health.

Diabetes & Endocrinology news Pediatrics Specialties

Severe Childhood Obesity Linked to Elevated Health Risks

By MedXY 07/25/2025

A new study highlights the growing prevalence of extreme pediatric obesity in the U.S. and its association with serious metabolic and cardiovascular health risks, emphasizing the need for targeted interventions.

Diabetes & Endocrinology news Specialties

Unraveling the Gut-Brain Connection: How Our Brain Detects Glucose

By MedXY 07/25/2025

Scientists at KAIST have identified a unique gut-brain pathway that enables the brain to distinguish glucose from other nutrients, paving the way for novel treatments for metabolic disorders.

Diabetes & Endocrinology Infectious Diseases news

Impact of Obesity on Long COVID: Insights from Primate Studies

By MedXY 07/25/2025

Obesity influences the long-term effects of SARS-CoV-2, revealing diverse outcomes in primates and suggesting broader implications for humans.

Diabetes & Endocrinology news Specialties

Heart Risks Uncovered: Popular Diabetes Drug Glipizide Linked to Higher Cardiovascular Events, Study Reveals

By MedXY 07/24/2025

Recent research reveals glipizide, a common diabetes drug, increases cardiovascular risks compared to DPP-4 inhibitors. This challenges assumptions about sulfonylureas, urging personalized treatment considering heart health alongside glycemic control in type 2 diabetes management.